• Browse
    • Login
    View Item 
    •   DSpace Home
    • Investigación
    • Artículos
    • View Item
    •   DSpace Home
    • Investigación
    • Artículos
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Ceftaroline in complicated skin and skin-structure infections

    Thumbnail
    View/Open
    Hernandez P.O., Lema S., Tyring S.K., Mendoza N._2012.pdf (224.7Kb)
    Share this
    TY - GEN T1 - Ceftaroline in complicated skin and skin-structure infections UR - http://hdl.handle.net/20.500.12495/2658 PB - Dove Medical Press Ltd AB - ER - @misc{20.500.12495_2658, author = {}, title = {Ceftaroline in complicated skin and skin-structure infections}, year = {}, abstract = {}, url = {http://hdl.handle.net/20.500.12495/2658} }RT Generic T1 Ceftaroline in complicated skin and skin-structure infections LK http://hdl.handle.net/20.500.12495/2658 PB Dove Medical Press Ltd AB OL Spanish (121)
    Gestores bibliográficos
    Refworks
    Zotero
    BibTeX
    CiteULike
    Author
    Hernandez, Paul O.
    Tyring, Stephen 
    Lema, Sergio
    Mendoza, Natalia
    Date
    2012
    Published in
    Infection and Drug Resistance, 1178-6973, Vol.5, 2012, p.23-35
    Published for
    Dove Medical Press Ltd
    URI
    http://hdl.handle.net/20.500.12495/2658
    Source's URL
    https://www.dovepress.com/ceftaroline-in-complicated-skin-and-skin-structure-infections-peer-reviewed-article-IDR
    DOI
    https://dx.doi.org/10.2147%2FIDR.S17432

    Citación

         
    Metadata
    Show full item record
    Documents PDF
    Abstract
    Ceftaroline is an advanced-generation cephalosporin antibiotic recently approved by the US Food and Drug Administration for the treatment of complicated skin and skin-structure infections (cSSSIs). This intravenous broad-spectrum antibiotic exerts potent bactericidal activity by inhibiting bacterial cell wall synthesis. A high affinity for the penicillin-binding protein 2a (PBP2a) of methicillin-resistant Staphylococcus aureus (MRSA) makes the drug especially beneficial to patients with MRSA cSSSIs. Ceftaroline has proved in multiple well-conducted clinical trials to have an excellent safety and efficacy profile. In adjusted doses it is also recommended for patients with renal or hepatic impairment. Furthermore, the clinical effectiveness and high cure rate demonstrated by ceftaroline in cSSSIs, including those caused by MRSA and other multidrug-resistant strains, warrants its consideration as a first-line treatment option for cSSSIs. This article reviews ceftaroline and its pharmacology, efficacy, and safety data to further elucidate its role in the treatment of cSSSIs.
    Keywords
    Ceftaroline
    Cephalosporin
    Complicated skin and skin-structure infections
    Topics
    Staphylococcus aureus
    Insuficiencia renal
    Enfermedades de la Piel
    Collections
    • Artículos [1458]

    Browse

    All of DSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    LoginRegister
    GTM statisticsGTM statistics
    Contacto Repositorio Institucional

    Teléfono: (571) 648 9000 Ext: 1546 - Correo: adminrepositorio@unbosque.edu.co

    Universidad El Bosque

    Instalaciones Bogotá

    Av. Cra. 9 No. 131 A - 02
    Línea gratuita:
    018000 113033
    PBX: (571) 648 9000

    Sede

    Instalaciones Chía

    Autopista Norte
    Km. 20 costado occidental
    Vía Chía - Bogotá
    Teléfono: 676 3110
    Línea gratuita: 018000 113033
    PBX: (571) 648 9000

    Sede Chía

    Admisiones

    PBX.: 648 9000
    Línea gratuita:
    018000 113033
    Edificio Fundadores
    Av. Cra. 9 No. 131 A - 02
    Skype: /uelbosque
    Correo electrónico:
    atencionalusuario@unbosque.edu.co

    Participante

    ACE Internationalization Lab

    Información Legal

    • Valores Pecuniarios
    • Estatuto General
    • Reglamento Estudiantil
    • Estatuto Docente
    • Política de Bienestar Universitario
    • Política de Tratamiento de Datos Personales
    • Términos y Condiciones de Uso del Sitio
    • Aviso de Privacidad
    • Información Tributaria

    Vigilada Mineducación. Personería Jurídica otorgada mediante resolución 11153 del 4 de agosto de 1978.